Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
LeVqBrtH3MUkwYJG
